3074 articles
Updated AHA/ACC guidelines maintain 130/80 mmHg threshold for diabetes patients, emphasizing earlier intervention to prevent cardiovascular complications.
Japanese Society of Hypertension unveils comprehensive program targeting morning hypertension, which affects 70% of patients despite treatment.
Comprehensive review reveals hexokinase method as the most precise technique for glucose testing in clinical laboratories.
NAD+ precursor supplementation restored fertility markers and improved embryo development in diabetes-induced reproductive dysfunction.
Nicotinamide riboside prevents moyamoya-like brain vessel blockages by fixing cellular energy production in smooth muscle cells.
New research reveals how berberine protects the heart in diabetes by activating cellular cleanup of harmful fat accumulation.
First clinical trial of NAD+ precursor in Werner syndrome patients shows improved arterial stiffness and reduced skin ulcers with no serious side effects.
New research reveals how IGF2BP3 protein promotes triple-negative breast cancer spread by hijacking cellular recycling processes.
Phase 1/2 umbrella trial matches glioblastoma patients to targeted treatments based on tumor genetics, with temsirolimus showing significant benefit.
New research reveals how IGF2BP3 protein promotes inflammation and tissue damage in rheumatoid arthritis through RNA modifications.
Engineered green tea compound nanoparticles activate cellular powerhouses to suppress tumor growth and improve immune response against melanoma.
Comprehensive review finds limited human data supporting off-label rapamycin use for healthy aging despite strong animal studies.
